thorium-227 attached to a PSMA antibody.

Email this conversation Print this conversation

User

Posted 01 Nov 2018 at 11:35

This may be a trial to look out for as it seems it may be carried out at the Royal Marsden.

https://prostatecancerinfolink.net/2018/10/30/newest-radiopharmaceutical-thorium-227-psma-antibody/

https://clinicaltrials.gov/ct2/show/NCT03724747

Roy

User

Posted 01 Nov 2018 at 12:51

Thanks for posting Roy. I feel sure that all the research that is going into this sort of area will lead to more effective down the line treatment options for men in the not very distant future.

Barry

User

Posted 01 Nov 2018 at 18:56

Hi Barry

if the old saying "follow the money" is anything to go by, then I think this link will show the promising use of this type of treatment may have on PCa and why Novartis has bought the rights to LU-177, Ac-225 and also PSMA. They must think there is money to be made.

https://prostatecancerinfolink.net/2018/10/19/novartis-acquires-developers-of-lu-177-psma-617-and-ac-225-psma-617/

Roy

Edited by member 01 Nov 2018 at 18:56 | Reason: Not specified

Email this conversation Print this conversation

Join the online community now.

Click through to become a member and gain access to support, information and real time replies.